SCHEMBL233470

SCHEMBL233470

COc1ccc(N(c2ccc(OC)cc2)c2ccc3c(c2)C2(c4cc(N(c5ccc(OC)cc5)c5ccc(OC)cc5)ccc4-3)c3cc(N(c4ccc(OC)cc4)c4ccc(OC)cc4)ccc3-c3ccc(N(c4ccc(OC)cc4)c4ccc(OC)cc4)cc32)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 4/20 0.39
CA2 P00918 4/20 0.39
CA7 P43166 3/20 0.39
CA9 Q16790 3/20 0.39
CA12 O43570 1/20 0.39
CA14 Q9ULX7 1/20 0.39
SLC2A1 P11166 1/20 0.37
PDK2 Q15119 3/20 0.36
PDE4D Q08499 3/20 0.35
CA4 P22748 1/20 0.35
ACHE P22303 1/20 0.34
ENPP2 Q13822 1/20 0.34
APP P05067 2/20 0.34
MAOA P21397 1/20 0.34
MAOB P27338 1/20 0.34
MEN1 O00255 2/20 0.33
MAPT P10636 2/20 0.33
KMT2A Q03164 2/20 0.33
MAPK1 P28482 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29350801 1.00 CA1 (0.39) CA1CA2CA7CA9CA12
SCHEMBL29349668 1.00 CA1 (0.39) CA1CA2CA7CA9CA12
SCHEMBL13642611 0.94 ACHE (0.47) CA1CA2CA7CA9CA12
SCHEMBL12376870 0.94 CA4 (0.39) PDK2CA4KMT2AHPGD
SCHEMBL19319144 0.94 ACHE (0.47) CA1CA2CA7CA9CA12
SCHEMBL24606931 0.94 PDK2 (0.36) CA1CA2CA7CA9CA12
SCHEMBL25874573 0.94 ACHE (0.47) CA1CA2CA7CA9CA12
SCHEMBL16190340 0.92 PDK2 (0.47) PDK2APPMAPTMAPK1SMN1; SMN2
SCHEMBL29352894 0.92 PDK2 (0.44) PDK2PDE4DMEN1KMT2A
SCHEMBL29589092 0.92 PDK2 (0.44) PDK2PDE4DMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1793 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4746649-A1 PEROVSKITE BATTERY AND PREPARATION METHOD THEREFOR, AND ELECTRIC DEVICE Contemporary Amperex Technology Co., Limited (CN) 2026-05-20 EP claimed
EP-4406387-B1 AN ORGANIC ELECTRONIC DEVICE COMPRISING A SUBSTRATE, AN ANODE LAYER, A CATHODE LAYER, AT LEAST ONE FIRST EMISSION LAYER, AND A HOLE INJECTION LAYER, WHEREIN THE HOLE INJECTION LAYER COMPRISES A METAL COMPLEX OF FORMULA (I) AND A COMPOUND OF FORMULA (II), WHEREIN THE HOLE INJECTION LAYER IS ARRANGED BETWEEN THE ANODE LAYER AND THE AT LEAST ONE FIRST EMISSION LAYER NOVALED GMBH (DE) 2026-05-20 EP claimed
US-12635260-B2 Waveguide edge having reduced reflectivity SNAP INC. (US) 2026-05-19 US claimed
US-20260130107-A1 CHIRAL-STRUCTURED HETEROINTERFACES ENABLE DURABLE PEROVSKITE SOLAR CELLS UNIV HONG KONG SCIENCE & TECH (CN) 2026-05-07 US claimed
EP-4518635-B1 ORGANIC ELECTRONIC DEVICE COMPRISING A HOLE INJECTION LAYER, WHEREIN THE HOLE INJECTION LAYER COMPRISES A COMPOUND OF FORMULA (I) AND A COMPOUND OF FORMULA (III) NOVALED GMBH (DE) 2026-03-25 EP claimed
US-12581795-B2 Display device and method for manufacturing same SHARP KABUSHIKI KAISHA (JP) 2026-03-17 US claimed
US-20260033118-A1 Photovoltaic Devices and Methods UNIV FLORIDA STATE RES FOUND INC (US) 2026-01-29 US claimed
US-20250374750-A1 COMPOSITE, FILM, AND PHOTOELECTRIC DEVICE GUANGDONG JUHUA RESEARCH INSTITUTE OF ADVANCED DISPLAY (CN) 2025-12-04 US claimed
US-20250374743-A1 PEROVSKITE BATTERY AND ELECTRIC DEVICE CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) 2025-12-04 US claimed
EP-4626193-A1 PEROVSKITE BATTERY AND ELECTRIC DEVICE Contemporary Amperex Technology Co., Limited (CN) 2025-10-01 EP claimed
EP-2940751-A2 Method for preparing perovskite film and solar cell thereof National Central University (TW) 2015-11-04 EP claimed
US-20150311364-A1 METHOD FOR PREPARING PEROVSKITE FILM AND SOLAR CELL THEREOF NATIONAL CENTRAL UNIVERSITY 2015-10-29 US claimed
EP-2846371-A1 Inverted solar cell and process for producing the same Ecole Polytechnique Fédérale de Lausanne (EPFL) (CH) 2015-03-11 EP claimed
WO-2014202965-A1 PHOTOACTIVE LAYER PRODUCTION PROCESS ISIS INNOVATION LIMITED (GB) 2014-12-24 WO claimed
US-20140335648-A1 MANUFACTURING METHOD OF SOLID-STATE DYE-SENSITIZED SOLAR CELLS AND ELECTROLYTE FILLING DEVICE USED THEREFOR KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2014-11-13 US claimed
US-20140116509-A1 Solid-State Dye-Sensitized Solar Cell Using Oxidative Dopant SHARP LABORATORIES OF AMERICA, INC. (SLA) 2014-05-01 US claimed
US-20130291941-A1 Solid-State Dye-Sensitized Solar Cell Using Sodium or Potassium Ionic Dopant SHARP LABORATORIES OF AMERICA, INC. 2013-11-07 US claimed
US-8093489-B2 Photovoltaic devices fabricated from nanostructured template NANOSOLAR, INC. (US) 2012-01-10 US claimed
US-7605327-B2 Solar cells; charge transfer compounds; electroconductivity; semiconductors; radiation transparent; chemical vapor deposition; electroless plating NANOSOLAR, INC. (US) 2009-10-20 US claimed
US-20050098204-A1 Solar cells; charge transfer compounds; electroconductivity; semiconductors; radiation transparent; chemical vapor deposition; electroless plating NANOSOLAR, INC. (US) 2005-05-12 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260130107-A1 CHIRAL-STRUCTURED HETEROINTERFACES ENABLE DURABLE PEROVSKITE SOLAR CELLS SLC6A6, SLC6A12, SLC9A2 CA1 249/4885CA2 144/4885CA7 866/4885
US-12581795-B2 Display device and method for manufacturing same EPHA4, NECTIN4, L1CAM CA1 2936/4885CA2 4283/4885CA7 3240/4885
US-12635260-B2 Waveguide edge having reduced reflectivity VEGFA, DNMT1, DSP CA1 712/4885CA2 3122/4885CA7 2166/4885
US-20260033118-A1 Photovoltaic Devices and Methods DCX, SLC9A2, SLC9A3 CA1 1150/4885CA2 648/4885CA7 1177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.